These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 9453014

  • 1. A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly.
    Schuster H, Toka O, Toka HR, Busjahn A, Oztekin O, Wienker TF, Bilginturan N, Bähring S, Skrabal F, Haller H, Luft FC.
    Kidney Int; 1998 Jan; 53(1):167-72. PubMed ID: 9453014
    [Abstract] [Full Text] [Related]

  • 2. Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
    Chen AX, Jerums G, Baqar S, Lambert E, Somarajah G, Thomas G, O'Callaghan C, MacIsaac RJ, Ekinci EI.
    Clin Sci (Lond); 2015 Sep; 129(5):415-22. PubMed ID: 25849646
    [Abstract] [Full Text] [Related]

  • 3. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 4. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 6. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA, Chang SM, Chou TC.
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [Abstract] [Full Text] [Related]

  • 7. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J, Mora-Macià J, Castellet R, del Río G.
    Med Clin (Barc); 1994 Jan 22; 102(2):41-5. PubMed ID: 8133694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 22; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 10. Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension.
    Schuster H, Wienker TF, Toka HR, Bähring S, Jeschke E, Toka O, Busjahn A, Hempel A, Tahlhammer C, Oelkers W, Kunze J, Bilginturan N, Haller H, Luft FC.
    Hypertension; 1996 Dec 22; 28(6):1085-92. PubMed ID: 8952601
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA, Schrover IM, Visseren FL, Scheffer PG, Oey PL, Danser AH, Spiering W.
    J Hypertens; 2013 Feb 22; 31(2):393-403. PubMed ID: 23235355
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 22; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 13. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K.
    J Cardiovasc Pharmacol; 2008 Jun 22; 51(6):590-5. PubMed ID: 18520951
    [Abstract] [Full Text] [Related]

  • 14. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ, Bhandari SK, Shi J, Kalantar-Zadeh K, Rasgon SA, Sealey JE, Laragh JH.
    Am J Hypertens; 2012 Mar 22; 25(3):379-88. PubMed ID: 22158065
    [Abstract] [Full Text] [Related]

  • 15. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.
    Pediatr Nephrol; 2002 May 22; 17(5):345-50. PubMed ID: 12042891
    [Abstract] [Full Text] [Related]

  • 16. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec 22; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 17. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May 22; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 22; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 19. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 22; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 20. Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension.
    Overlack A, Ruppert M, Kolloch R, Kraft K, Stumpe KO.
    Am J Hypertens; 1995 Aug 22; 8(8):829-36. PubMed ID: 7576400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.